查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542501

全球癌症免疫疗法药物发现外包市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 164 Pages | 商品交期: 最快1-2个工作天内

价格

全球癌症免疫疗法药物发现外包市场的需求预计将从2023年的15.1亿美元达到2032年近37.4亿美元的市场规模，2024-2032年研究期间的复合年增长率为10.56%。

癌症免疫治疗药物发现外包包括与外部公司签约以进行与癌症免疫治疗相关的研发活动。这种外包模式使製药和生技公司能够利用内部可能无法获得的专业知识、技术和资源。该过程包括临床前研究、临床试验和开发新型免疫治疗剂，旨在利用人体的免疫系统来靶向和消除癌细胞。透过外包这些活动，公司可以加速药物开发、降低成本并更有效地管理风险。这种策略方法有助于获得尖端技术和专业知识，同时允许组织在竞争激烈的癌症治疗领域中专注于其核心能力和策略目标。

市场动态

由于开发新型癌症免疫疗法的复杂性和成本不断增加，癌症免疫疗法药物发现外包市场正在经历大幅成长。外包为製药和生物技术公司提供了对成功发现和开发这些疗法至关重要的专业知识和先进技术。透过与经验丰富的合约研究组织 (CRO) 和其他服务提供者合作，公司可以简化药物发现流程、缩短上市时间并更有效地管理成本。人们越来越重视免疫疗法作为癌症治疗的革命性方法，这也推动了癌症免疫疗法药物发现外包市场的成长。免疫疗法利用人体的免疫系统来靶向癌细胞，在临床试验中显示出有希望的结果，并且正在成为首选的治疗方式。这一趋势推动了对外包服务的需求，这些服务可以加速新免疫疗法药物的开发并提高临床试验效率。

此外，CAR-T 细胞疗法和检查点抑制剂等免疫治疗技术的进步为外包合作伙伴关係创造了新的机会。开发这些尖端治疗方法需要专业知识和基础设施，这使得外包对许多公司具有吸引力。另一个积极的市场趋势是製药公司和外包提供者之间的合作和策略联盟数量不断增加。这些合作关係使公司能够获得更多资源和专业知识，促进更有效率和有效的药物发现过程。然而，智慧财产权和资料安全问题可能会抑制癌症免疫治疗药物发现外包市场的成长。与外包相关的风险，包括潜在的智慧财产权窃盗和资料洩露，可能会影响公司参与外包安排的意愿并影响整体市场动态。

这项详细的市场研究以从多个来源获得的资料为中心，并使用多种工具进行分析，包括波特五力分析、市场吸引力分析和价值链分析。这些工具用于深入了解市场的潜在价值，为业务策略家提供最新的成长机会。此外，这些工具还提供了全球癌症免疫疗法药物发现外包市场中每个应用/产品细分的详细分析。

市场区隔

广泛的癌症免疫治疗药物发现外包市场已细分为药物类型、服务类型和癌症类型。该报告根据地理细分研究了这些子集。策略师可以获得详细的洞察并针对特定市场制定适当的策略。这些细节将导致采取有针对性的方法，从而识别更好的机会。

依药物类型

  • 单株抗体
  • 免疫调节剂
  • 溶瘤病毒疗法和癌症疫苗
  • 其他的

按服务类型

  • 目标识别和验证
  • 铅筛选与表征
  • 基于细胞的检测

按癌症类型

  • 肺
  • 胸部
  • 大肠直肠
  • 黑色素瘤
  • 摄护腺
  • 头部和颈部
  • 卵巢
  • 胰
  • 区域分析
  • 此外，该报告还包括地理细分，主要关注北美、欧洲、亚太地区、拉丁美洲以及中东和非洲地区当前和预测的癌症免疫疗法药物发现外包需求。该报告进一步关注所有地区对各个应用领域的需求。
  • 该报告还涵盖了详细的竞争格局，包括在全球市场上运营的主要参与者的公司简介。癌症免疫疗法药物发现外包市场的主要参与者包括Aquila BioMedical、BPS Bioscience, Inc.、Celentyx Ltd.、Covance, Inc.、Crown Bioscience, Inc.、DiscoverX Corporation、Explicyte、Genscript Biotech Corporation、HD Biosciences Co.、 Ltd.、Horizo​​n Discovery Group PLC、ImmunXperts SA、Molecular Imaging, Inc.、Personalis, Inc.、Promega Corporation 和STC Biologics。深入了解竞争前景，包括未来产能、关键併购、财务概况、合作伙伴关係、合作、新产品发布、新产品开发和其他发展，并提供总部信息

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 癌症免疫疗法药物发现外包市场亮点
  • 全球癌症免疫疗法药物发现外包市场概况

第 3 章：癌症免疫治疗药物发现外包 - 产业分析

  • 介绍
  • 癌症免疫治疗药物发现外包市场的市场驱动因素
  • 癌症免疫治疗药物发现外包市场的市场约束
  • 癌症免疫疗法药物发现外包市场的机会
  • 癌症免疫疗法药物发现外包市场趋势
  • 波特对癌症免疫疗法药物发现外包市场的五力分析
  • 癌症免疫疗法药物发现外包市场吸引力分析
    • 按药物类型分類的市场吸引力分析
    • 按服务类型分類的市场吸引力分析
    • 按癌症类型分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 癌症免疫治疗药物发现外包价值链分析
  • 癌症免疫治疗药物发现外包原料分析
    • 原料清单
    • 癌症免疫疗法药物研发外包原料厂商名单
    • 癌症免疫疗法药物发现外包关键原料价格趋势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球癌症免疫疗法药物发现外包市场分析：按药物类型

  • 按药物类型概述
  • 按药物类型分類的全球癌症免疫疗法药物发现外包市场分析
  • 单株抗体市场分析：按地区
  • 免疫调节剂市场分析：按地区
  • 溶瘤病毒疗法和癌症疫苗的市场分析：按地区
  • 其他市场分析：按地区

第 6 章：全球癌症免疫疗法药物发现外包市场分析：按服务类型

  • 按服务类型概述
  • 按服务类型分類的全球癌症免疫疗法药物发现外包市场分析
  • 目标识别和验证的市场分析：按地区
  • 铅筛选和表征的市场分析：按地区
  • 细胞检测市场分析：按地区

第 7 章：全球癌症免疫疗法药物发现外包市场分析：按癌症类型

  • 按癌症类型概述
  • 按癌症类型分類的全球癌症免疫疗法药物发现外包市场分析
  • 肺臟市场分析：按地区
  • 乳房市场分析：按地区
  • 大肠直肠市场分析：按地区
  • 黑色素瘤市场分析：按地区
  • 摄护腺市场分析：按地区
  • 头颈部市场分析：按地区
  • 卵巢市场分析：按地区
  • 胰臟市场分析：按地区

第 8 章：全球癌症免疫疗法药物发现外包市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美洲
    • 概述
    • 北美癌症免疫疗法药物发现外包市场估计：按国家/地区
    • 美国
    • 北美其他地区
  • 欧洲
    • 概述
    • 欧洲癌症免疫治疗药物发现外包市场估计：按细分市场
    • 欧洲癌症免疫疗法药物发现外包市场估计：按国家/地区
    • 英国
    • 法国
    • 德国
    • 欧洲其他地区
  • 亚太地区
    • 概述
    • 亚太地区癌症免疫治疗药物发现外包市场估计：按细分市场
    • 亚太地区癌症免疫治疗药物发现外包市场估计：按国家/地区
    • 中国
    • 日本
    • 印度
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲癌症免疫治疗药物发现外包市场估计：按细分市场
    • 拉丁美洲癌症免疫疗法药物发现外包市场估计：按国家/地区
    • 巴西
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲癌症免疫疗法药物发现外包市场估计：按细分市场
    • 中东和非洲癌症免疫疗法药物发现外包市场估计：按国家/地区
    • 中东
    • 非洲

第 9 章：癌症免疫疗法药物发现外包公司的竞争格局

  • 癌症免疫疗法药物发现外包市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Aquila BioMedical
    • 公司概况
    • 产品
    • 最新动态
  • BPS Bioscience, Inc.
    • 公司概况
    • 产品
    • 最新动态
  • Celentyx Ltd.
    • 公司概况
    • 产品
    • 最新动态
  • Covance, Inc.
    • 公司概况
    • 产品
    • 最新动态
  • Crown Bioscience, Inc.
    • 公司概况
    • 产品
    • 最新动态
  • DiscoverX Corporation
    • 公司概况
    • 产品
    • 最新动态
  • Explicyte
    • 公司概况
    • 产品
    • 最新动态
  • Genscript Biotech Corporation
    • 公司概况
    • 产品
    • 最新动态
  • HD Biosciences Co., Ltd.
    • 公司概况
    • 产品
    • 最新动态
  • Horizon Discovery Group PLC
    • 公司概况
    • 产品
    • 最新动态
  • ImmunXperts SA
    • 公司概况
    • 产品
    • 最新动态
  • Molecular Imaging, Inc.
    • 公司概况
    • 产品
    • 最新动态
  • Personalis, Inc.
    • 公司概况
    • 产品
    • 最新动态
  • Promega Corporation
    • 公司概况
    • 产品
    • 最新动态
  • STC Biologics
    • 公司概况
    • 产品
    • 最新动态

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR11211227

The global demand for Cancer Immunotherapy Drug Discovery Outsourcing Market is presumed to reach the market size of nearly USD 3.74 Billion by 2032 from USD 1.51 Billion in 2023 with a CAGR of 10.56% under the study period 2024 - 2032.

Cancer immunotherapy drug discovery outsourcing includes contracting external firms to conduct research and development activities related to immunotherapy treatments for cancer. This outsourcing model allows pharmaceutical and biotechnology companies to leverage specialized expertise, technologies, and resources that may not be available in-house. The process includes preclinical research, clinical trials, and developing novel immunotherapeutic agents designed to harness the body's immune system to target & eliminate cancer cells. By outsourcing these activities, companies can accelerate drug development, reduce costs, and manage risks more effectively. This strategic approach facilitates access to cutting-edge technologies and expertise while allowing organizations to focus on their core competencies and strategic objectives in the highly competitive field of cancer therapeutics.

MARKET DYNAMICS

The cancer immunotherapy drug discovery outsourcing market is experiencing substantial growth driven by the increasing complexity and cost of developing novel cancer immunotherapies. Outsourcing provides pharmaceutical and biotechnology companies access to specialized expertise and advanced technologies crucial for successfully discovering and developing these therapies. By partnering with experienced contract research organizations (CROs) and other service providers, companies can streamline their drug discovery processes, reduce time-to-market, and manage costs more effectively. The growing emphasis on immunotherapy as a revolutionary approach to cancer treatment is also fuelling cancer immunotherapy drug discovery outsourcing market growth. Immunotherapy, which leverages the body's immune system to target cancer cells, has shown promising results in clinical trials and is becoming a preferred treatment modality. This trend drives demand for outsourcing services that can accelerate the development of new immunotherapeutic agents and enhance clinical trial efficiency.

Furthermore, advancements in immunotherapy technologies, such as CAR-T cell therapy and checkpoint inhibitors, create new opportunities for outsourcing partnerships. The need for specialized knowledge and infrastructure to develop these cutting-edge treatments makes outsourcing attractive for many companies. Another positive market trend is the increasing number of collaborations and strategic alliances between pharmaceutical companies and outsourcing providers. These partnerships enable companies to access more resources and expertise, facilitating more efficient and effective drug discovery processes. However, intellectual property and data security concerns may restrain cancer immunotherapy drug discovery outsourcing market growth. Risks associated with outsourcing, including potential IP theft and data breaches, can impact the willingness of companies to engage in outsourcing arrangements and affect overall market dynamics.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of cancer immunotherapy drug discovery outsourcing.

Market Segmentation

The broad cancer immunotherapy drug discovery outsourcing market has been sub-grouped into drug type, service type, and cancer type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Drug Type

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies And Cancer Vaccines
  • Others

By Service Type

  • Target Identification And Validation
  • Lead Screening And Characterization
  • Cell Based Assays

By Cancer Type

  • Lung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head And Neck
  • Ovarian
  • Pancreatic
  • Regional Analysis
  • Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for cancer immunotherapy drug discovery outsourcing in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
  • The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the cancer immunotherapy drug discovery outsourcing market includes Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd., Covance, Inc., Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co., Ltd., Horizon Discovery Group PLC, ImmunXperts SA, Molecular Imaging, Inc., Personalis, Inc., Promega Corporation and STC Biologics. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 2.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot

3 . CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.3. Market Restraints of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.4. Opportunities of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.5. Trends of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.6. Porter's Five Force Analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.7. Cancer Immunotherapy Drug Discovery Outsourcing Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Drug Type
    • 3.7.2 Market Attractive Analysis by Service Type
    • 3.7.3 Market Attractive Analysis by Cancer Type
    • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Cancer Immunotherapy Drug Discovery Outsourcing Value Chain Analysis
  • 4.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Manufactures List
    • 4.2.3. Price Trend of Cancer Immunotherapy Drug Discovery Outsourcing Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE

  • 5.1 Overview by Drug Type
  • 5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type
  • 5.3 Market Analysis of Monoclonal Antibodies by Regions
  • 5.4 Market Analysis of Immunomodulators by Regions
  • 5.5 Market Analysis of Oncolytic Viral Therapies And Cancer Vaccines by Regions
  • 5.6 Market Analysis of Others by Regions

6 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE

  • 6.1 Overview by Service Type
  • 6.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type
  • 6.3 Market Analysis of Target Identification And Validation by Regions
  • 6.4 Market Analysis of Lead Screening And Characterization by Regions
  • 6.5 Market Analysis of Cell Based Assays by Regions

7 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE

  • 7.1 Overview by Cancer Type
  • 7.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type
  • 7.3 Market Analysis of Lung by Regions
  • 7.4 Market Analysis of Breast by Regions
  • 7.5 Market Analysis of Colorectal by Regions
  • 7.6 Market Analysis of Melanoma by Regions
  • 7.7 Market Analysis of Prostate by Regions
  • 7.8 Market Analysis of Head And Neck by Regions
  • 7.9 Market Analysis of Ovarian by Regions
  • 7.10. Market Analysis of Pancreatic by Regions

8 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview
    • 8.3.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.3.3. United State
    • 8.3.4. Rest of North America
  • 8.4. Europe
    • 8.4.1. Overview
    • 8.4.2. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.4.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7 Rest of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview
    • 8.5.2. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.5.3. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. Japan
    • 8.5.6. India
    • 8.5.7. Rest of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview
    • 8.6.2. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.6.3. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview
    • 8.7.2. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.7.4. Middle East
    • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES

  • 9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Aquila BioMedical
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. BPS Bioscience, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Celentyx Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Covance, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Crown Bioscience, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. DiscoverX Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Explicyte
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Genscript Biotech Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. HD Biosciences Co., Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Horizon Discovery Group PLC
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. ImmunXperts SA
    • 10.13.1. Company Overview
    • 10.13.2. Financials
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. Molecular Imaging, Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financials
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Personalis, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financials
    • 10.15.3. Products
    • 10.15.4. Recent Developments
  • 10.16. Promega Corporation
    • 10.16.1. Company Overview
    • 10.16.2. Financials
    • 10.16.3. Products
    • 10.16.4. Recent Developments
  • 10.17. STC Biologics
    • 10.17.1. Company Overview
    • 10.17.2. Financials
    • 10.17.3. Products
    • 10.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Monoclonal Antibodies by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Immunomodulators by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Oncolytic Viral Therapies And Cancer Vaccines by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Others by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Target Identification And Validation by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lead Screening And Characterization by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Cell Based Assays by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lung by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Breast by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Colorectal by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Melanoma by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Prostate by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Head And Neck by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Ovarian by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Pancreatic by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Geography (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type(USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis

LIST OF FIGURES

  • Research Scope of Cancer Immunotherapy Drug Discovery Outsourcing Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Type
  • Market Attractiveness Analysis by Service Type
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Monoclonal Antibodies by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Immunomodulators by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Oncolytic Viral Therapies And Cancer Vaccines by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Others by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Target Identification And Validation by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lead Screening And Characterization by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Cell Based Assays by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lung by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Breast by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Colorectal by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Melanoma by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Prostate by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Head And Neck by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Ovarian by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Pancreatic by Geography (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market by Revenue
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market by Revenue
  • Recent Development in Cancer Immunotherapy Drug Discovery Outsourcing Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.